Does Serum Delta FSH Level Provided with High Starting Dose FSH Differ Among Various Ovarian Responses?
Open Access
- 12 January 2025
- journal article
- Published by Uludag Universitesi Tip Fakultesi Dergisi in Uludağ Üniversitesi Tıp Fakültesi Dergisi
- Vol. 50 (3) , 375-380
Abstract
The objective of this study is to evaluate whether serum delta FSH levels (the percentage difference of serum FSH between antagonist starting day and basal serum FSH level) differ between patients with different COH responses (poor, suboptimal response and normoresponders) who stimulated with a high (300 IU) fixed recombinant FSH dose during flexible antagonist cycles. This study is a retrospective cross sectional cohort study conducted in a tertiary ART Center. 122 women were evaluated, of which, 51 were poor responders, 52 had suboptimal response and 19 had normal response. The primary outcome is to evaluate the spot serum FSH levels on the first day of GnRH antagonist dose administration and the delta FSH levels between groups. Basal serum FSH levels differed significantly between (7[5.2-8.6], 5.7[4.6-7.2], 4.8[4.1-5.3] poor, suboptimal and normoresponders respectively; pKeywords
This publication has 16 references indexed in Scilit:
- Insights from clinical experience in treating IVF poor respondersReproductive BioMedicine Online, 2018
- Individualized versus standard FSH dosing in women starting IVF/ICSI: an RCT. Part 1: The predicted poor responderHuman Reproduction, 2017
- The Vienna consensus: report of an expert meeting on the development of art laboratory performance indicators†‡Human Reproduction Open, 2017
- Ovarian response to controlled ovarian hyperstimulation: what does serum FSH say?Human Reproduction, 2017
- 450 IU versus 600 IU gonadotropin for controlled ovarian stimulation in poor responders: a randomized controlled trialFertility and Sterility, 2015
- Ovarian response prediction in GnRH antagonist treatment for IVF using anti-Müllerian hormoneHuman Reproduction, 2014
- Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cyclesHuman Reproduction, 2011
- The clinical analysis of poor ovarian response in in-vitro-fertilization embryo-transfer among Chinese couplesJournal of Assisted Reproduction and Genetics, 2008
- A randomized, double-blind, multicentre clinical trial comparing starting doses of 150 and 200 IU of recombinant FSH in women treated with the GnRH antagonist ganirelix for assisted reproductionHuman Reproduction, 2004
- Induction of follicular growth using recombinant human follicle-stimulating hormone in two volunteer women with hypogonadotropic hypogonadismFertility and Sterility, 1993